Cognition is our ability to interact with the world around us.
It includes functions such as:
Dementia is a general term for a decline in cognitive function, including memory, thinking, and decision-making, that interferes with daily life.
After completing this interactive lesson, you should be able to answer the following questions:
⏱ 2 min read
Dementia occurs when certain areas of the brain become damaged, leading to weakened cognitive functions. When this impairment is severe enough to affect a person's ability to function independently day-to-day, it is classified as dementia. Symptoms of dementia vary depending on which cognitive functions are affected:
Dementia is most commonly caused by toxic proteins in the brain or blood vessel damage due to age, high blood pressure, or previous strokes. Dementia caused by blood vessel damage is known as vascular dementia. Neurodegenerative disorders, such as Alzheimer disease, are caused by toxic proteins. Other protein-related conditions include dementia with Lewy bodies, frontotemporal dementia, and Parkinson disease dementia.
Other problems in the body can impact the brain and cause memory and thinking issues, which may be reversible. These causes include:
It is important to be assessed by a healthcare professional to determine the correct diagnosis and exclude these other causes before diagnosing dementia.
Currently, there is no cure for dementia. However, treating reversible causes of cognitive impairment can often yield positive results, and in some cases, memory and thinking problems may be completely reversible. For dementia caused by blood vessel damage, managing blood pressure, cholesterol levels, and diabetes is crucial to slowing the progression of cognitive symptoms.
Cognitive enhancing medications
There are medications, known as cognitive enhancers, that can help manage dementia symptoms. These include cholinesterase inhibitors and memantine. Cholinesterase inhibitors boost levels of neurotransmitters in the brain, helping it function better, while memantine aims to limit damage to nerve cells. Although these medications do not treat the underlying cause of dementia, they can sometimes slow its progression and have a modest effect on function for some people.
Activities to promote brain health
Engaging in activities that promote brain health is always encouraged. These activities include regular exercise, proper nutrition, staying cognitively and socially active, and maintaining good blood vessel health.
Learn more about how to promote brain health.
Tell us what you think about this content with a quick 3-item survey. Your participation will help us improve this resource.
Take SurveyExplore our content on dementia risk reduction.
Learn the basics of dementia, including causes, symptoms, stages, treatments, safety issues, caregiver wellness and supports, and how to promote brain health. (12 minutes)
Understand the difference between normal aging and mild cognitive impairment, its causes, diagnosis, management, treatment, and steps to take after a diagnosis. (20 minutes)
Explore the signs, symptoms, and causes of Alzheimer disease, vascular, Lewy body, frontotemporal, and Parkinson disease dementias. (25 minutes)
Learn how to manage dementia's cognitive, behavioural, emotional and psychiatric symptoms and how disease modification strategies address its underlying causes. (20 minutes)
Neuropsychiatrist, Professor; Faculty of Health Sciences, McMaster University
Consultant Geriatrician and Internist, Vancouver Coastal Health
About this Project
Who authored and edited this page?
This page was developed by the Division of e-Learning Innovation team and Dr. Anthony J. Levinson, MD, FRCPC (Psychiatry) and Dr. Richard Sztramko, MD, FRCPC (Internal Medicine, Geriatrics).
Dr. Levinson is a psychiatrist and professor in the Department of Psychiatry and Behaviour Neurosciences, Faculty of Health Sciences, McMaster University. He is the Director of the Division of e-Learning Innovation, as well as the John Evans Chair in Health Sciences Educational Research at McMaster. He practices Consultation-Liaison Psychiatry, with a special focus on dementia and other cognitive and mental disorders in the medically ill. He is also the co-developer, along with Dr. Sztramko, of the iGeriCare.ca dementia care partner resource, and one of the co-leads for the McMaster Optimal Aging Portal. He and his team are passionate about developing high-quality digital content to improve people's understanding about health.
Dr. Sztramko is a consultant geriatrician and internist for Vancouver Coastal Health who also completed a fellowship in Behavioural Neurology at the University of California San Francisco (UCSF). Through his work with patients with dementia and their families, Dr. Sztramko came to understand that there is a desire and need for online education about dementia that has been developed by experts in geriatrics. This inspired him to pursue the creation of iGeriCare, on which this content is based.
A team of experts in geriatrics and mental health reviewed the content for accuracy, and care partners of people living with dementia participated in the design and development of the content on iGeriCare.
Are there any important disclosures or conflicts of interest?
Dr. Levinson receives funding from McMaster University as part of his research chair. He has also received several grants for his work from not-for-profit granting agencies. He has no conflicts of interest with respect to the pharmaceutical industry; and there were no funds from industry used in the development of this content or website.
Dr. Sztramko has no conflicts of interest to disclose with respect to development of this content.
When was it last reviewed?
November 29, 2024.
What references and evidence were used to create this content?
The content was written and adapted by experts in geriatrics and neuropsychiatry based on credible, high-quality, evidence-based sources such as the National Institute on Aging, National Institute of Neurological Disorders and Stroke, American Academy of Neurology, National Institutes of Health, the American Psychiatric Association and the DSM-5 TR (2022), Health Quality Ontario quality standards, Recommendations of the 5th Canadian Consensus Conference on the diagnosis and treatment of dementia (2020), the Cochrane Library, the Alzheimer Society of Canada, UptoDate®, the World Health Organization (WHO), and others.
Who funded it?
The initial development of some of this content was funded by the Centre for Aging and Brain Health Innovation (CABHI), powered by Baycrest, along with additional support from the Hamilton Health Sciences Foundation and Geras Centre for Aging Research. Subsequent funding was through support from the McMaster Optimal Aging Portal, with support from the Labarge Optimal Aging Initiative, the Faculty of Health Sciences, and the McMaster Institute for Research on Aging (MIRA) at McMaster University. There are no conflicts of interest to declare. There was no industry funding for this content.